They have found a new treatment for pancreatic cancer, one of the deadliest tumors.
He pancreas cancer It is the ninth most common tumor in Spain, but due to its high mortality rate, it is the third cause of cancer death in the country.
Spanish Association Against Cancer It is estimated that every year about 233,000 new cases throughout the world, it is more common in men, with 60% of them in developed countries of Europe, America and Australia. IN Spainit is assumed that every year 7,765 new cases were identified..
Read also
For this reason, the conclusions of A. recent US study about a new experimental therapy that offers hope against pancreas cancer. What is it about.
What are the first symptoms of pancreatic cancer?
In the early stages of the disease shows no symptoms. They usually occur in later stages. nonspecific signs, How:
- Light stool.
Read also
Risk factors for pancreatic cancer
There are many cause pancreatic canceralthough many of these aspects are not the direct cause of the disease.
However, these risk factors increase the likelihood of developing cell DNA damage what can cause pancreatic cancer.
Below we describe the main risk factors of this disease:
- Personal story diabetes or chronic pancreatitis.
- Family history pancreatic cancer or pancreatitis.
- Presence hereditary diseasessuch as colon, breast and ovarian cancer, among others.
Risk factors for pancreatic cancer
What is a new experimental therapy for pancreatic cancer that targets the immune system?
After clinical trial in which there are 6 groups of patients with metastatic pancreatic cancerwho are in the second stage of research being carried out Georgetown University Lombardi Comprehensive Cancer CenterEncouraging results were obtained.
As stated earlier, pancreas cancer diagnosed in advanced stages since there is still no way to detect it in the first months. That’s why Immunotherapy doesn’t work The tumor is very advanced and immune cells cannot penetrate the tumor.
According to the doctor Benjamin Adam Weinbergchief investigator of the trial, “He exclusive use of immunotherapy also did not work usually due to the inability of immune cells to penetrate the tumor. It goes through dense fibrous tissue separating tumors from the immune system».
For this reason, “had to find different approach treatment“Weinberg explains. So a new empirical therapy has been created that seems to have great results because it does the immune system stop or retard growth tumor cells. This is achieved by combining monoclonal antibodies, pembrozilumabwith him experimental drug BXCL701.
This information in no way replaces a doctor’s diagnosis or prescription. It is important to consult a specialist when symptoms appear and never self-medicate.